We are live on ! Find out more
ETC

Exchange Traded Concepts Portfolio holdings

AUM $21.9B
1-Year Est. Return 68.6%
This Fund
S&P 500
This Quarter Est. Return
+8.73%
1 Year Est. Return
+68.6%
3 Year Est. Return
+158.93%
5 Year Est. Return
+186.62%
10 Year Est. Return
AUM
$3.88B
AUM Growth
+$136M
Cap. Flow
-$98.6M
Cap. Flow %
-2.54%
Top 10 Hldgs %
15.31%
Holding
1,480
New
256
Increased
503
Reduced
456
Closed
248

Sector Composition

Rank Sector Weight
1 Technology 24.25%
2 Energy 11.27%
3 Healthcare 9.69%
4 Communication Services 7.57%
5 Industrials 7.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AUTL
776
Autolus Therapeutics
AUTL
$389M
$319K 0.01%
49,989
+1,140
+2% +$7.11K
ZNTL icon
777
Zentalis Pharmaceuticals
ZNTL
$332M
$318K 0.01%
20,201
+14,212
+237% +$195K
CRCT icon
778
Cricut
CRCT
$1.01B
$318K 0.01%
+66,851
New +$356K
EE icon
779
Excelerate Energy
EE
$1.19B
$318K 0.01%
19,826
-4,485
-18% -$67.2K
FHTX icon
780
Foghorn Therapeutics
FHTX
$278M
$316K 0.01%
47,097
+25,562
+119% +$142K
MTD icon
781
Mettler-Toledo International
MTD
$28.1B
$316K 0.01%
237
-266
-53% -$328K
IMMR icon
782
Immersion
IMMR
$243M
$312K 0.01%
41,731
-15,859
-28% -$113K
AZO icon
783
AutoZone
AZO
$51.3B
$312K 0.01%
99
-331
-77% -$946K
IBRX icon
784
ImmunityBio
IBRX
$7.15B
$312K 0.01%
58,032
-19,854
-25% -$89.9K
BPMC
785
DELISTED
Blueprint Medicines
BPMC
$312K 0.01%
3,285
+515
+19% +$44.2K
WSO icon
786
Watsco Inc
WSO
$13.2B
$309K 0.01%
+716
New +$288K
BCYC
787
Bicycle Therapeutics
BCYC
$269M
$309K 0.01%
12,421
+5,694
+85% +$121K
YMAB
788
DELISTED
Y-mAbs Therapeutics
YMAB
$309K 0.01%
18,996
-9,099
-32% -$123K
IMCR icon
789
Immunocore
IMCR
$1.7B
$308K 0.01%
4,738
+2,082
+78% +$143K
MPWR icon
790
Monolithic Power Systems
MPWR
$61.4B
$306K 0.01%
451
-233
-34% -$156K
RAPT
791
DELISTED
RAPT Therapeutics
RAPT
$304K 0.01%
4,235
+3,336
+371% +$464K
PRLD icon
792
Prelude Therapeutics
PRLD
$375M
$303K 0.01%
63,887
+19,800
+45% +$77K
ARE icon
793
Alexandria Real Estate Equities
ARE
$9.37B
$301K 0.01%
2,337
+259
+12% +$31.9K
TTD icon
794
Trade Desk
TTD
$8.97B
$300K 0.01%
3,431
+3,397
+9,991% +$257K
AURA icon
795
Aura Biosciences
AURA
$725M
$300K 0.01%
38,195
+23,296
+156% +$193K
SNDX icon
796
Syndax Pharmaceuticals
SNDX
$1.7B
$299K 0.01%
12,580
+4,504
+56% +$100K
SDGR icon
797
Schrodinger
SDGR
$1.13B
$299K 0.01%
11,065
+6,821
+161% +$191K
NRIX icon
798
Nurix Therapeutics
NRIX
$2.45B
$298K 0.01%
20,295
+4,472
+28% +$48.1K
IOVA icon
799
Iovance Biotherapeutics
IOVA
$2.04B
$297K 0.01%
20,052
-6,551
-25% -$76.2K
CMG icon
800
Chipotle Mexican Grill
CMG
$43.9B
$296K 0.01%
5,100
-20,150
-80% -$1.03M

Similar funds

Exchange Traded Concepts's Q1 2024 Portfolio in Review

As of Q1 2024, Exchange Traded Concepts held 1,480 positions worth $3.88B, up 3.6% from $3.74B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Exchange Traded Concepts's Q1 2024 filing shows 256 new, 503 increased, 456 reduced and 248 closed positions. Its largest new stake was JPMorgan Equity Premium Income ETF: 966,844 shares worth $55.9M. The largest sale was Vanguard Short-Term Bond ETF, an estimated $55.9M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Energy and Healthcare.

  • Exchange Traded Concepts's largest Q1 2024 buy was JPMorgan Equity Premium Income ETF: 966,844 shares worth $55.9M.
  • Exchange Traded Concepts added most to Janus Henderson AAA CLO ETF in Q1 2024, an estimated $39.3M increase.
  • Exchange Traded Concepts's biggest Q1 2024 reduction was State Street Utilities Select Sector SPDR ETF, cutting an estimated $39.2M.
  • Exchange Traded Concepts fully exited Vanguard Short-Term Bond ETF in Q1 2024, selling an estimated $55.9M.
  • Exchange Traded Concepts's ten largest holdings make up 15% of its $3.88B portfolio in Q1 2024.
  • Exchange Traded Concepts opened 256 new positions and closed 248 in Q1 2024.
  • Exchange Traded Concepts's portfolio value rose 3.6% quarter-over-quarter to $3.88B.

Based on Exchange Traded Concepts's 13F filing for Q1 2024, filed 15 Apr 2024.